Prognostic value of p53 in non-small cell lung cancer: relationship with proliferating cell nuclear antigen and cigarette smoking.

[1]  J. Izbicki,et al.  Immunohistochemical detection of P53 protein is not associated with a poor prognosis in non-small-cell lung cancer. , 1995, The Journal of thoracic and cardiovascular surgery.

[2]  S. Rodenhuis,et al.  Comparative analysis of p53 gene mutations and protein accumulation in human non‐small‐cell lung cancer , 1995, International journal of cancer.

[3]  H. Dosaka-akita,et al.  Abnormal p53 expression in human lung cancer is associated with histologic subtypes and patient smoking history. , 1994, American journal of clinical pathology.

[4]  C. Harris,et al.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.

[5]  M. Volm,et al.  Immunohistochemical detection of p53 in non-small-cell lung cancer. , 1994, Journal of the National Cancer Institute.

[6]  J. Izbicki,et al.  p53 in non-small-cell lung cancer. , 1994, Journal of the National Cancer Institute.

[7]  S. Steinberg,et al.  Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. , 1994, Cancer research.

[8]  E. van Marck,et al.  Proliferation in malignant mesothelioma as determined by mitosis counts and immunoreactivity for proliferating cell nuclear antigen (PCNA) , 1994, The Journal of pathology.

[9]  P. Korkolopoulou,et al.  p53 expression in oat and non-oat small cell lung carcinomas: correlations with proliferating cell nuclear antigen. , 1993, Journal of clinical pathology.

[10]  W. W. Nichols,et al.  p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. , 1993, Journal of the National Cancer Institute.

[11]  Johnson Be,et al.  The biology of lung cancer. , 1993, Seminars in oncology.

[12]  M. Subler,et al.  Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells , 1992, Journal of virology.

[13]  D. Lane,et al.  The relationship of p53 immunostaining to survival in carcinoma of the lung. , 1992, British Journal of Cancer.

[14]  C. Angeletti,et al.  The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node‐negative non‐small cell lung cancer , 1992, Cancer.

[15]  D. Quinlan,et al.  Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. , 1992, Cancer research.

[16]  Max H. Myers,et al.  Manual for Staging of Cancer , 1992 .

[17]  R. Ueda,et al.  p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. , 1992, Cancer research.

[18]  E. Sondik.  Smoking-attributable cancer mortality. , 1991, Journal of the National Cancer Institute.

[19]  A. Puisieux,et al.  Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. , 1991, Cancer research.

[20]  T. Pechacek,et al.  Smoking-attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States? , 1991, Journal of the National Cancer Institute.

[21]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[22]  D. Lane,et al.  Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some, neoplasms , 1990, The Journal of pathology.

[23]  W. Bodmer,et al.  p53 mutations in colorectal cancer. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Harris,et al.  Increased expression of mutant forms of p53 oncogene in primary lung cancer , 1990, The Lancet.

[25]  T Takahashi,et al.  Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer. , 1993, Cancer research.

[26]  A. Levine.  The tumor suppressor genes. , 1993, Annual review of biochemistry.

[27]  O. Auerbach.  Histological Typing Of Lung Tumors , 1968 .